12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

HyperAcute Lung: Additional Phase I/II data

Additional data from 28 evaluable patients in the Phase II portion of a single-arm, open-label Phase I/II trial in 54 patients showed that HyperAcute Lung produced 8 cases of stable disease, including 1 patient who initially progressed then regressed. In the 8 patients that achieved stable disease, PFS was >=16 weeks and...

Read the full 238 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >